2m 2m 2m 2m 2m 2m 2m
Inventiva Sp ADS (IVA)
NASDAQ
$4.03-$0.06 (-1.44%)
Price as of Jun 03, 2026 6:54 PM EDT- $1.0BMarket Cap
- 12.98%1-Year Change
- BiotechnologyIndustry
Inventiva Sp ADS (IVA)
$4.03-$0.06 (-1.44%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 4.5M -51.27% | 9.2M -47.36% | 17.5M +43.50% | 12.2M +190.39% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 4.5M -51.27% | 9.2M -47.36% | 17.5M +43.50% | 12.2M +190.39% | |
Sales and Marketing Expense | 5.0M +154.12% | 2.0M -1.36% | 2.0M -23.34% | 2.6M +609.62% | |
Research and Development Expense | -87.0M -4.22% | -90.9M -17.39% | -110.0M +81.93% | -60.5M +24.80% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 47.9M +202.39% | 15.8M +14.47% | 13.8M +7.16% | 12.9M +15.75% | |
Operating Profit | -141.0M +44.54% | -97.6M -5.02% | -102.7M +79.84% | -57.1M +9.59% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -33.6M +175.61% | -12.2M +135.19% | -5.2M +786.64% | -584,000 +323.19% | |
Interest Income and Expense and Net | -33.6M +175.61% | -12.2M +135.19% | -5.2M +786.64% | -584,000 +323.19% | |
Total Nonoperating Income and Expense | 33.6M +175.61% | 12.2M +135.19% | 5.2M +786.64% | 584,000 +323.19% | |
Income before Taxes | -354.1M +92.24% | -184.2M +66.82% | -110.4M +103.46% | -54.3M +9.35% | |
Income Taxes | 22,000 -92.97% | 313,000 -48.43% | 607,000 +3,135.00% | -20,000 -105.49% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -354.1M +92.24% | -184.2M +66.82% | -110.4M +103.46% | -54.3M +9.35% | |
Net Income from Continuing Operations Applicable to Common | -354.1M +92.24% | -184.2M +66.82% | -110.4M +103.46% | -54.3M +9.35% | |
Basic EPS and Net Income | -1.90 -38.31% | -3.08 +26.75% | -2.43 +85.50% | -1.31 +3.15% | |
Diluted EPS and Net Income | -1.90 -38.31% | -3.08 +26.75% | -2.43 +85.50% | -1.31 +3.15% | |
Basic Weighted Average Shares | 186.8M +212.49% | 59.8M +31.81% | 45.4M +9.41% | 41.4M +5.83% | |
Diluted Weighted Average Shares | 186.8M +212.49% | 59.8M +31.81% | 45.4M +9.41% | 41.4M +5.83% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 99.3M +2.85% | 96.6M +258.73% | 26.9M -68.97% | 86.7M +0.21% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 99.3M +2.85% | 96.6M +258.73% | 26.9M -68.97% | 86.7M +0.21% | |
Total Current Assets | 244.5M +119.23% | 111.5M +131.40% | 48.2M -54.70% | 106.4M -7.96% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | 3.7M -59.85% | 9.1M +23.56% | 7.4M +131.07% | |
Total Long-Term Assets | 5.0M -32.38% | 7.5M -65.11% | 21.4M +122.13% | 9.6M +50.14% | |
Total Assets | 249.5M +109.73% | 119.0M +71.03% | 69.6M -40.04% | 116.0M -4.90% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 77.4M -35.91% | 120.7M +140.70% | 50.2M +63.38% | 30.7M +34.34% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 316,000 +5,166.67% | |
Total Long-Term Liabilities | 200.7M +91.31% | 104.9M +103.92% | 51.4M +29.14% | 39.8M +287.95% | |
Total Liabilities | 278.0M +23.23% | 225.6M +122.08% | 101.6M N/A | N/A N/A | |
Retained Earnings | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Stockholders Equity | -28.5M -73.26% | -106.6M +232.94% | -32.0M -170.44% | 45.5M -48.83% | |
Total Shares Outstanding | 193.2M +102.00% | 95.7M +83.56% | 52.1M +23.69% | 42.1M +3.08% | |
Cash Flow | |||||
Cash from Operating Activities | -104.9M +22.06% | -85.9M +5.29% | -81.6M +81.66% | -44.9M -5.67% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -133.2M -1,623.00% | 8.7M +213.12% | -7.7M -187.18% | 8.9M +594.59% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 241.3M +65.73% | 145.6M +400.64% | 29.1M -21.97% | 37.3M +46.45% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -3,145.51% +196.63% | -1,060.41% +80.44% | -587.68% +25.33% | -468.92% -62.26% | |
Return on Assets | -192.22% -1.64% | -195.42% +64.20% | -119.02% +160.94% | -45.61% +19.88% | |
Return on Equity | 523.99% +97.24% | 265.67% +116.17% | -1,642.76% +1,933.12% | -80.80% +62.85% | |
Revenue Growth | -51.27% +8.26% | -47.36% -208.87% | 43.50% -77.15% | 190.39% -81.47% | |
Current Ratio | 3.16 +242.07% | 0.92 -3.86% | 0.96 -72.27% | 3.47 -31.49% | |
Cash Ratio | 1.28 +60.48% | 0.80 +49.02% | 0.54 -81.00% | 2.83 -25.41% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow